Javascript must be enabled to continue!
Hospital Variation in Time to Epinephrine for Nonshockable In-Hospital Cardiac Arrest
View through CrossRef
Background:
For patients with in-hospital cardiac arrests attributable to nonshockable rhythms, delays in epinephrine administration beyond 5 minutes is associated with worse survival. However, the extent of hospital variation in delayed epinephrine administration and its effect on hospital-level outcomes is unknown.
Methods:
Within Get With The Guidelines-Resuscitation, we identified 103 932 adult patients (≥18 years) at 548 hospitals with an in-hospital cardiac arrest attributable to a nonshockable rhythm who received at least 1 dose of epinephrine between 2000 and 2014. We constructed 2-level hierarchical regression models to quantify hospital variation in rates of delayed epinephrine administration (>5 minutes) and its association with hospital rates of survival to discharge and survival with functional recovery.
Results:
Overall, 13 213 (12.7%) patients had delays to epinephrine, and this rate varied markedly across hospitals (range, 0%–53.8%). The odds of delay in epinephrine administration were 58% higher at 1 randomly selected hospital in comparison with a similar patient at another randomly selected hospital (median odds ratio, 1.58; 95% confidence interval, 1.51–1.64). The median risk-standardized survival rate was 12.0% (range, 5.4%–31.9%), and the risk-standardized survival with functional recovery was 7.4% (range, 0.9%–30.8%). There was an inverse correlation between a hospital’s rate of delayed epinephrine administration and its risk-standardized rate of survival to discharge (ρ=–0.22,
P
<0.0001) and survival with functional recovery (ρ=–0.14,
P
=0.001). In comparison with a median survival rate of 12.9% (interquartile range, 11.1%–15.4%) at hospitals in the lowest quartile of epinephrine delay, risk-standardized survival was 16% lower at hospitals in the quartile with the highest rate of epinephrine delays (10.8%; interquartile range, 9.7%–12.7%).
Conclusions:
Delays in epinephrine administration following in-hospital cardiac arrest are common and variy across hospitals. Hospitals with high rates of delayed epinephrine administration had lower rates of overall survival for in-hospital cardiac arrest attributable to nonshockable rhythm. Further studies are needed to determine whether improving hospital performance on time to epinephrine administration, especially at hospitals with poor performance on this metric, will lead to improved outcomes.
Ovid Technologies (Wolters Kluwer Health)
Title: Hospital Variation in Time to Epinephrine for Nonshockable In-Hospital Cardiac Arrest
Description:
Background:
For patients with in-hospital cardiac arrests attributable to nonshockable rhythms, delays in epinephrine administration beyond 5 minutes is associated with worse survival.
However, the extent of hospital variation in delayed epinephrine administration and its effect on hospital-level outcomes is unknown.
Methods:
Within Get With The Guidelines-Resuscitation, we identified 103 932 adult patients (≥18 years) at 548 hospitals with an in-hospital cardiac arrest attributable to a nonshockable rhythm who received at least 1 dose of epinephrine between 2000 and 2014.
We constructed 2-level hierarchical regression models to quantify hospital variation in rates of delayed epinephrine administration (>5 minutes) and its association with hospital rates of survival to discharge and survival with functional recovery.
Results:
Overall, 13 213 (12.
7%) patients had delays to epinephrine, and this rate varied markedly across hospitals (range, 0%–53.
8%).
The odds of delay in epinephrine administration were 58% higher at 1 randomly selected hospital in comparison with a similar patient at another randomly selected hospital (median odds ratio, 1.
58; 95% confidence interval, 1.
51–1.
64).
The median risk-standardized survival rate was 12.
0% (range, 5.
4%–31.
9%), and the risk-standardized survival with functional recovery was 7.
4% (range, 0.
9%–30.
8%).
There was an inverse correlation between a hospital’s rate of delayed epinephrine administration and its risk-standardized rate of survival to discharge (ρ=–0.
22,
P
<0.
0001) and survival with functional recovery (ρ=–0.
14,
P
=0.
001).
In comparison with a median survival rate of 12.
9% (interquartile range, 11.
1%–15.
4%) at hospitals in the lowest quartile of epinephrine delay, risk-standardized survival was 16% lower at hospitals in the quartile with the highest rate of epinephrine delays (10.
8%; interquartile range, 9.
7%–12.
7%).
Conclusions:
Delays in epinephrine administration following in-hospital cardiac arrest are common and variy across hospitals.
Hospitals with high rates of delayed epinephrine administration had lower rates of overall survival for in-hospital cardiac arrest attributable to nonshockable rhythm.
Further studies are needed to determine whether improving hospital performance on time to epinephrine administration, especially at hospitals with poor performance on this metric, will lead to improved outcomes.
Related Results
Outcomes with intracoronary vs. intravenous epinephrine in cardiac arrest
Outcomes with intracoronary vs. intravenous epinephrine in cardiac arrest
Abstract
Background
Advanced Cardiovascular Life Support (ACLS) guidelines recommend intravenous (IV) and intraosseous (IO) epin...
CDP-CHOLINE IMPROVES THE OUTCOME OF CARDIAC ARREST VERSUS EPINEPHRINE IN RATS
CDP-CHOLINE IMPROVES THE OUTCOME OF CARDIAC ARREST VERSUS EPINEPHRINE IN RATS
Objectives
CDP-Choline is a cholinergic agent which can both stimulate the cholinergic pathway and increase blood pressure. We aimed to investigate the effects of...
GW24-e2104 Epinephrine enhanced LPS-induced pro-inflammatory cytokines release by BMMCs: a cross-talking between catecholamine, circadian rhythm and inflammation
GW24-e2104 Epinephrine enhanced LPS-induced pro-inflammatory cytokines release by BMMCs: a cross-talking between catecholamine, circadian rhythm and inflammation
Objectives
Occurring of acute coronary syndromes (ACSs) displayed circadian rhythms as well as the levels of catecholamines and pro-inflammatory cytokines in vivo...
Calcium attenuates epinephrine's beta-adrenergic effects in postoperative heart surgery patients.
Calcium attenuates epinephrine's beta-adrenergic effects in postoperative heart surgery patients.
Epinephrine and calcium possess both cardiac inotropic and vasopressor activity. In addition, epinephrine's cardiovascular effects are mediated via increases in intracellular calci...
Mortality, morbidity & clinical outcome with different types of vasopressors in out of hospital cardiac arrest patients- a systematic review and meta-analysis
Mortality, morbidity & clinical outcome with different types of vasopressors in out of hospital cardiac arrest patients- a systematic review and meta-analysis
Abstract
Background & objective
Despite their continued use, the effectiveness and safety of vasopressors in post-cardiac arrest patients remain...
THE ROLE OF EPINEPHRINE IN THE REACTIONS PRODUCED BY THE ENDOTOXINS OF GRAM-NEGATIVE BACTERIA
THE ROLE OF EPINEPHRINE IN THE REACTIONS PRODUCED BY THE ENDOTOXINS OF GRAM-NEGATIVE BACTERIA
The effects of endotoxin on the epinephrine reactivity of blood vessels in the rat mesoappendix have been studied. Following intravenous injection of a relatively small, sublethal ...
Abstract 4137905: The association between prehospital epinephrine administration and short-term outcomes in patients with shockable out-of-hospital cardiac arrest and extracorporeal cardiopulmonary resuscitation: a propensity matched analysis
Abstract 4137905: The association between prehospital epinephrine administration and short-term outcomes in patients with shockable out-of-hospital cardiac arrest and extracorporeal cardiopulmonary resuscitation: a propensity matched analysis
Background:
In out-of-hospital cardiac arrest (OHCA) patients with an initial shockable rhythm, epinephrine increases the likelihood of return of spontaneous circulatio...
TOPICAL EPINEPHRINE VERSUS INFILTRATIVE EPINEPHRINE -WHAT IS SAFE FOR HEMOSTASIS IN ENDOSCOPIC SINUS SURGERY?
TOPICAL EPINEPHRINE VERSUS INFILTRATIVE EPINEPHRINE -WHAT IS SAFE FOR HEMOSTASIS IN ENDOSCOPIC SINUS SURGERY?
Aim: The study intents to compare the safety & efcacy of topical application versus intranasal injection of epinephrine during endoscopic sinus
surgery(ESS) under general anae...

